The Company is invited to President Securities'
2022Q1 Spring Investment Forum
Date of events
2022/03/17
To which item it meets
paragraph 12
Statement
1.Date of institutional investor conference:2022/03/17
2.Time of institutional investor conference:02:00 pm
(Taiwan Time)
3.Location of institutional investor conference:Grand Mayfull Hotel Taipei
4.Outline of institutional investor conference:Report of the
Company's business performance and financial results.
5.Any other matters that need to be specified:N/A
For the complete financial and business information, please refer
to the Market Observation Post System and see under Investor
Conferences.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Universal Vision Biotechnology Co. Ltd. published this content on 15 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 March 2022 10:41:01 UTC.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. 
